Livostin Gtt Opht 0.5mg/ml Fl 4ml

Livostin eye drops is a medicine used to treat allergies around the eyes. Its effects come on quickly and last for several hours. Livostin eye drops quickly relieve the typical signs of conjunctivitis of a seasonal allergic nature, such as itching in the eye, redness, swelling of the conjunctiva and eyelids and tearing.

Swissmedic-approved patient information

What are Livostin eye drops and when are they used?

Livostin eye drops is a medicine used to treat allergies in the eye area. Its effects come on quickly and last for several hours. Livostin eye drops quickly relieve the typical signs of conjunctivitis of a seasonal allergic nature, such as itching in the eye, redness, swelling of the conjunctiva and eyelids and tearing.

What should be considered?

Note for contact lens wearers: Soft, hydrophilic contact lenses should not be worn during treatment with Livostin eye drops.

When should Livostin eye drops not be used?

Livostin eye drops should not be used if you are hypersensitive to one of the ingredients. If you are unsure, ask your doctor, pharmacist or druggist.

When is caution required when using Livostin eye drops?

Do not use Livostin eye drops for longer than 2 weeks without a prescription. If the symptoms persist after this time, the doctor should be consulted. If prescribed by the doctor, the drug can be used for longer than 2 weeks. In this case, however, it should not be used for more than 3 months without medical controls.

Children under the age of 6 should not use Livostin eye drops.

After instillation of Livostin eye drops, undesirable effects such as eye irritation, pain, swelling, itching, redness, burning in the eyes, watery eyes and blurred vision may occur, which can affect vision. Patients should therefore only drive or operate machines with caution.

This medicinal product contains 0.15 mg benzalkonium chloride and 9.5 mg phosphates per ml of suspension.

Benzalkonium chloride can be absorbed by soft contact lenses and may discolour the contact lenses. You must remove the contact lenses before using this medicine and wait 15 minutes before putting them back in.

Benzalkonium chloride can also cause eye irritation, particularly if you have dry eyes or diseases of the cornea (the clear layer at the front of the eye). Contact your doctor if you get an unusual feeling, burning or pain in your eye after using this medicine.

Tell your doctor, pharmacist or druggist if you

• suffer from other diseases,
• have allergies or
• take other medicines (including those you bought yourself!) or use them externally!

Can Livostin eye drops be used during pregnancy or breastfeeding?

Based on previous experience, there is no known risk for the child when used as directed. However, systematic scientific studies have never been carried out. Livostin eye drops may only be used during pregnancy with the permission of the doctor. The use of Livostin eye drops during breast-feeding is not recommended.

How do you use Livostin eye drops?

Shake the vial before use. To maintain the sterility of the eye drops, do not touch the dropper tip with your hands or eyes. Unless otherwise prescribed by the doctor, Livostin eye drops are used as follows:

Adults and adolescents over 12 years of age: 1 drop in each eye, 2 times a day. If the symptoms are severe, the dosage can be increased to 1 drop 3-4 times a day.

Children from 6-12 years: 1 drop in each eye 2 times a day.

Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Livostin eye drops have?

Very common (affects more than 1 in 10 people)

• Eye irritation

Common (affects 1 to 10 users in 100)

• Headache
• Eye pain
• Blurred vision

Uncommon (affects 1 to 10 users in 1000)

• Swelling of the eyelids

Frequency not known (cannot be estimated from the available data)

• Reactions at the application site, these can manifest as follows : Burning, redness, pain, swelling or itching of the eyes, as well as watery eyes and blurred vision
• Conjunctivitis
• Swelling of the eyes
• Inflammation of the eyelid
• Blood accumulation in the eye
• Hypersensitivity reactions
• Allergic reactions (anaphylaxis)
• Swelling of the face (angioedema), which can also affect adjacent tissue, e.g. Lips, cheeks or eyelids may be affected
• Irritation of the skin areas that have come into contact with the medicine
• Hives
• Palpitation of the heart

If you have severe damage to the cornea (transparent layer at the front of the eye), phosphates may very rarely cause cloudiness (cloudy patches) of the cornea due to calcium build-up during treatment.

If you get any side effects, talk to your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.

What else needs to be considered?

Shelf life

The medicinal product may only be used up to the date marked «EXP» on the container.

Use by after opening

Close the bottle immediately after use. Once opened, do not use for more than 1 month

Storage Instructions

Store at room temperature (15-25 °C). Keep out of reach of CHILDREN.

You can bring any remaining residue 1 month after opening the bottle to your point of sale (doctor, pharmacist or druggist) for professional disposal.

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Livostin eye drops contain?

1 ml sterile eye drop suspension (microsuspension) contains:

Active ingredients

0.5 mg levocabastine (as levocabastine hydrochloride)

Excipients

Propylene glycol (E 1520), benzalkonium chloride, disodium phosphate monohydrogen, sodium dihydrogen phosphate monohydrate, polysorbate 80, hypromellose 2910, edetate sodium, water for injections

Approval number

50496 (Swissmedic)

Where can you get Livostin eye drops? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

5 ml plastic vial containing 4 ml micro suspension.

Authorization holder

Janssen-Cilag AG, Zug, ZG

This leaflet was last checked by the Medicines Agency (Swissmedic) in July 2022.